Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00124540
Status:
COMPLETED
Last Update Posted:
2008-05-28
First Post:
2005-07-26
Brief Title:
Misoprostol for Preventing Postpartum Hemorrhage
Sponsor:
Gynuity Health Projects
Organization:
Gynuity Health Projects
Study Overview
Official Title:
Misoprostol for Preventing Postpartum Hemorrhage
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This hospital-based multicenter randomized placebo-controlled trial will assess the effects of misoprostol as part of active management of the third stage of labor on postpartum blood loss complications and side effects Twelve hundred eligible women will receive routine oxytocics oxytocin 5-10 IU plus either 400 mcg sublingual misoprostol or placebo during or immediately after delivery The primary outcome will be measured blood loss of 500 mls within one hour after enrollment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None